[PBBANK] QoQ Annualized Quarter Result on 30-Sep-2011 [#3]

Announcement Date
17-Oct-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
30-Sep-2011 [#3]
Profit Trend
QoQ- 0.45%
YoY- 25.83%
View:
Show?
Annualized Quarter Result
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Revenue 13,678,580 13,493,800 12,756,360 12,579,636 12,324,522 11,966,428 11,035,597 15.40%
PBT 4,915,084 4,925,592 4,877,939 4,888,176 4,869,976 4,692,272 4,086,197 13.11%
Tax -1,132,922 -1,173,256 -1,153,436 -1,152,117 -1,148,000 -1,112,208 -987,120 9.62%
NP 3,782,162 3,752,336 3,724,503 3,736,058 3,721,976 3,580,064 3,099,077 14.21%
-
NP to SH 3,744,500 3,720,728 3,684,289 3,694,529 3,677,888 3,536,244 3,048,224 14.71%
-
Tax Rate 23.05% 23.82% 23.65% 23.57% 23.57% 23.70% 24.16% -
Total Cost 9,896,418 9,741,464 9,031,857 8,843,577 8,602,546 8,386,364 7,936,520 15.86%
-
Net Worth 16,628,709 15,682,767 15,721,970 10,505,734 10,506,637 10,507,922 13,011,769 17.78%
Dividend
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Div 1,400,784 - 1,680,969 933,843 1,400,884 - 2,027,953 -21.87%
Div Payout % 37.41% - 45.63% 25.28% 38.09% - 66.53% -
Equity
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Net Worth 16,628,709 15,682,767 15,721,970 10,505,734 10,506,637 10,507,922 13,011,769 17.78%
NOSH 3,501,960 3,502,650 3,502,020 3,501,911 3,502,212 3,502,640 3,496,471 0.10%
Ratio Analysis
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
NP Margin 27.65% 27.81% 29.20% 29.70% 30.20% 29.92% 28.08% -
ROE 22.52% 23.72% 23.43% 35.17% 35.01% 33.65% 23.43% -
Per Share
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
RPS 390.60 385.25 364.26 359.22 351.91 341.64 315.62 15.28%
EPS 106.92 106.24 105.20 105.49 105.02 100.96 87.18 14.59%
DPS 40.00 0.00 48.00 26.67 40.00 0.00 58.00 -21.95%
NAPS 4.7484 4.4774 4.4894 3.00 3.00 3.00 3.7214 17.65%
Adjusted Per Share Value based on latest NOSH - 3,502,704
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
RPS 70.47 69.52 65.72 64.81 63.49 61.65 56.85 15.40%
EPS 19.29 19.17 18.98 19.03 18.95 18.22 15.70 14.72%
DPS 7.22 0.00 8.66 4.81 7.22 0.00 10.45 -21.86%
NAPS 0.8567 0.8079 0.81 0.5412 0.5413 0.5413 0.6703 17.78%
Price Multiplier on Financial Quarter End Date
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Date 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 30/12/10 -
Price 13.76 13.64 13.38 12.20 13.30 13.12 13.02 -
P/RPS 3.52 3.54 3.67 3.40 3.78 3.84 4.13 -10.11%
P/EPS 12.87 12.84 12.72 11.56 12.66 13.00 14.93 -9.43%
EY 7.77 7.79 7.86 8.65 7.90 7.70 6.70 10.39%
DY 2.91 0.00 3.59 2.19 3.01 0.00 4.45 -24.68%
P/NAPS 2.90 3.05 2.98 4.07 4.43 4.37 3.50 -11.79%
Price Multiplier on Announcement Date
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Date 23/07/12 18/04/12 30/01/12 17/10/11 25/07/11 18/04/11 25/01/11 -
Price 14.34 13.78 13.52 12.50 13.36 13.06 13.34 -
P/RPS 3.67 3.58 3.71 3.48 3.80 3.82 4.23 -9.04%
P/EPS 13.41 12.97 12.85 11.85 12.72 12.94 15.30 -8.42%
EY 7.46 7.71 7.78 8.44 7.86 7.73 6.54 9.17%
DY 2.79 0.00 3.55 2.13 2.99 0.00 4.35 -25.64%
P/NAPS 3.02 3.08 3.01 4.17 4.45 4.35 3.58 -10.73%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment